These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8941670)

  • 1. Progression of mycosis fungoides is associated with increasing cutaneous expression of interleukin-10 mRNA.
    Asadullah K; Döcke WD; Haeussler A; Sterry W; Volk HD
    J Invest Dermatol; 1996 Dec; 107(6):833-7. PubMed ID: 8941670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile whereas Sezary syndrome expresses a Th2-type profile.
    Saed G; Fivenson DP; Naidu Y; Nickoloff BJ
    J Invest Dermatol; 1994 Jul; 103(1):29-33. PubMed ID: 8027577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-7 mRNA is not overexpressed in mycosis fungoides and pleomorphic T-cell lymphoma and is likely to be an autocrine growth factor in vivo.
    Asadullah K; Haeussler A; Friedrich M; Siegling A; Olaizola-Horn S; Trefzer U; Volk HD; Sterry W
    Arch Dermatol Res; 1996 Dec; 289(1):9-13. PubMed ID: 9017129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal and cancer fibroblasts differentially regulate TWIST1, TOX and cytokine gene expression in cutaneous T-cell lymphoma.
    Mehdi SJ; Moerman-Herzog A; Wong HK
    BMC Cancer; 2021 May; 21(1):492. PubMed ID: 33941102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
    Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
    Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression dynamics of CXCL12 and CXCR4 during the progression of mycosis fungoides.
    Daggett RN; Kurata M; Abe S; Onishi I; Miura K; Sawada Y; Tanizawa T; Kitagawa M
    Br J Dermatol; 2014 Oct; 171(4):722-31. PubMed ID: 24725174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
    Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
    Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased interleukin-21 expression in skin and blood in advanced mycosis fungoides.
    Kabasawa M; Sugaya M; Oka T; Takahashi N; Kawaguchi M; Suga H; Miyagaki T; Takahashi T; Shibata S; Fujita H; Asano Y; Tada Y; Kadono T; Okochi H; Sato S
    J Dermatol; 2016 Jul; 43(7):819-22. PubMed ID: 26825047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and activity of IL-17 in cutaneous T-cell lymphomas (mycosis fungoides and Sezary syndrome).
    Cirée A; Michel L; Camilleri-Bröet S; Jean Louis F; Oster M; Flageul B; Senet P; Fossiez F; Fridman WH; Bachelez H; Tartour E
    Int J Cancer; 2004 Oct; 112(1):113-20. PubMed ID: 15305382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 4 and interferon-gamma expression of the dermal infiltrate in patients with erythroderma and mycosis fungoides. An immuno-histochemical study.
    Sigurdsson V; Toonstra J; Bihari IC; Bruijnzeel-Koomen CA; van Vloten WA; Thepen T
    J Cutan Pathol; 2000 Oct; 27(9):429-35. PubMed ID: 11028812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma.
    Vowels BR; Lessin SR; Cassin M; Jaworsky C; Benoit B; Wolfe JT; Rook AH
    J Invest Dermatol; 1994 Nov; 103(5):669-73. PubMed ID: 7963654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in IL-2 receptor levels between mycosis fungoides and cutaneous type adult T-cell leukemia/lymphoma in the early stages of the disease.
    Oishi M; Johno M; Ono T; Honda M
    J Invest Dermatol; 1994 May; 102(5):710-5. PubMed ID: 8176252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-15 and IL-16 overexpression in cutaneous T-cell lymphomas: stage-dependent increase in mycosis fungoides progression.
    Asadullah K; Haeussler-Quade A; Gellrich S; Hanneken S; Hansen-Hagge TE; Döcke WD; Volk HD; Sterry W
    Exp Dermatol; 2000 Aug; 9(4):248-51. PubMed ID: 10949545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune function abnormalities in peripheral blood mononuclear cell cytokine expression differentiates stages of cutaneous T-cell lymphoma/mycosis fungoides.
    Chong BF; Wilson AJ; Gibson HM; Hafner MS; Luo Y; Hedgcock CJ; Wong HK
    Clin Cancer Res; 2008 Feb; 14(3):646-53. PubMed ID: 18245523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The possible interaction between periostin expressed by cancer stroma and tumor-associated macrophages in developing mycosis fungoides.
    Furudate S; Fujimura T; Kakizaki A; Kambayashi Y; Asano M; Watabe A; Aiba S
    Exp Dermatol; 2016 Feb; 25(2):107-12. PubMed ID: 26441016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant expression of BCL11B in mycosis fungoides and its potential role in interferon-induced apoptosis.
    Gu X; Wang Y; Zhang G; Li W; Tu P
    J Dermatol; 2013 Aug; 40(8):596-605. PubMed ID: 23682716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic markers associated with progression in early mycosis fungoides.
    Johnson VE; Vonderheid EC; Hess AD; Eischen CM; McGirt LY
    J Eur Acad Dermatol Venereol; 2014 Nov; 28(11):1431-5. PubMed ID: 24171863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal expression of interleukin-23 in mycosis fungoides/Sézary syndrome lesions.
    Doherty SD; Ni X; Doherty CB; Jones D; Zhao X; Owen LB; Duvic M
    Arch Dermatol Res; 2006 Dec; 298(7):353-6. PubMed ID: 17021762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL32 is progressively expressed in mycosis fungoides independent of helper T-cell 2 and helper T-cell 9 polarization.
    Ohmatsu H; Humme D; Gulati N; Gonzalez J; Möbs M; Suárez-Fariñas M; Cardinale I; Mitsui H; Guttman-Yassky E; Sterry W; Krueger JG
    Cancer Immunol Res; 2014 Sep; 2(9):890-900. PubMed ID: 24938282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.